Part of the expanding PassProfessor catalog: This program is built — 1,500 original practice questions, weighted to NABP’s current MPJE Competency Statements — and it opens for enrollment soon as part of the expanding PassProfessor catalog. Join the notify list and we will email you when enrollment opens.
This program is part of the expanding PassProfessor catalog — join the notify list and we’ll email you when enrollment opens.
The District of Columbia MPJE is NABP’s Multistate Pharmacy Jurisprudence Examination as administered for District of Columbia pharmacist licensure: 120 questions in 2.5 hours at Pearson VUE — 100 scored plus 20 unscored pretest — mixing federal and District of Columbia law with no distinction between them, reported pass/fail. PassProfessor’s District of Columbia MPJE program, part of the expanding PassProfessor catalog, holds 1,500 original practice questions — an 800-question federal core intermixed with 700 District of Columbia questions — weighted to NABP’s current Competency Statements, priced at $49, and opening for enrollment soon.
What is included in the District of Columbia MPJE program?
A bank built the way the exam is built. The MPJE makes no distinction between federal and state questions, so neither does this bank: 800 federal-core questions and 700 District of Columbia questions are intermixed in a single 1,500-question bank, and where a District of Columbia rule differs from the federal rule, the District of Columbia rule keys the answer — the same instruction NABP gives on the exam itself.
An explanation on every question. Every one of the 1,500 questions carries an explanation of why the keyed answer is right. Jurisprudence is a subject where the tempting wrong answer is usually the other jurisdiction’s rule or the federal default, and the explanation names the distinction instead of leaving you to guess at it.
Practice exams at the real exam’s shape. A full practice exam draws 100 scored questions — the scored length of the real exam — across the four competency areas at their published weights, inside the real 150-minute clock. Draws are generated fresh for each attempt, questions you have not seen come first, and you never sit the same generated exam twice. Practice exams are scored against a 70% practice benchmark — a preparation target only, because the real MPJE reports pass/fail and NABP publishes no raw passing score.
Drills by competency area. Work one area at a time — Licensure and Personnel, Pharmacist Practice, Dispensing Requirements, or Pharmacy Operations — and your results break down by area, so a weak area shows up in your practice data before it shows up on a score report.
The real exam at a glance
Current as of November 2026, per NABP’s MPJE program pages and Competency Statements and District of Columbia Board of Pharmacy. Full detail — eligibility, application steps, retakes, test day — is in our District of Columbia MPJE exam guide.
| Exam fact | District of Columbia MPJE |
|---|---|
| Questions administered | 120 (100 scored + 20 unscored pretest, mixed in) |
| Time limit | 2.5 hours (150 minutes) |
| Format | Computer-based, multiple choice, at Pearson VUE |
| Federal vs. state questions | Intermixed with no distinction; each question is answered under the prevailing law of District of Columbia |
| Scoring | Pass/fail. NABP does not publish a raw passing score, and no percentage of correct answers is the passing standard |
| Passing score | No numeric passing score is published for this exam — the result is reported as pass or fail |
| Attempts | Up to 5 per jurisdiction |
| Fees | About $270 per attempt in NABP fees |
| Eligibility | Confirmed by NABP (the District of Columbia is one of the jurisdictions for which NABP confirms eligibility) |
| Score transfer | MPJE scores are not transferable between jurisdictions — a District of Columbia result applies to District of Columbia licensure only |
How does the practice map to the real exam?
| NABP competency area | Share of the real exam | Practice questions in this program | Questions per full practice exam |
|---|---|---|---|
| Area 1 — Licensure and Personnel | 22% | 333 | 22 |
| Area 2 — Pharmacist Practice | 33% | 498 | 33 |
| Area 3 — Dispensing Requirements | 24% | 358 | 24 |
| Area 4 — Pharmacy Operations | 21% | 311 | 21 |
The federal half of every MPJE is the same body of law, and it is larger than most candidates expect. The shared 800-question federal core in this program covers the Controlled Substances Act framework end to end: the five schedules, the rule that Schedule II prescriptions never refill, the five-refills-in-six-months limit for Schedules III and IV, emergency oral Schedule II orders and the prescriber’s seven-day follow-up duty, partial fills, pharmacist-to-pharmacist transfers of Schedules III–V, DEA registration and Form 222/CSOS ordering, biennial inventories, theft and loss reporting, and disposal. It covers the Food, Drug, and Cosmetic Act in the form the exam tests it — adulteration versus misbranding, generic substitution and Orange Book equivalence, container labeling, child-resistant packaging, Medication Guides and REMS programs, the three recall classes, expiration and beyond-use dating, DSCSA track-and-trace duties, and the line between 503A patient-specific compounding and 503B outsourcing facilities. It covers OBRA ’90 prospective drug review and counseling duties, USP <795>, <797> and <800> compounding standards, HIPAA’s treatment/payment/operations framework and breach-notification duties, and the personnel principles that hold in every state: the pharmacist-in-charge answers for the pharmacy’s compliance, technicians never counsel, and no dispensing happens when no pharmacist is on duty.
What District of Columbia law does the exam test?
Half of what makes the District of Columbia MPJE hard is that it is two bodies of law at once. The District half of this program is built on:
The District of Columbia questions in this bank are grounded in primary District sources read first-hand: the Health Occupations Revision Act (Title 3 of the D.C. Code, including the pharmacy provisions and the pharmacy technician subchapter), the pharmacy facility and prescription rules (Title 22-B of the District of Columbia Municipal Regulations, Chapters 19 and 13), the individual-licensure rules (Title 17 DCMR Chapters 65, 99 and 103), the Controlled Substances Act (Title 48, Chapter 9), the generic-substitution law (Title 48, Chapter 8, Subchapter III), and the Prescription Drug Monitoring Program law (Title 48, Chapter 8G). The District splits its two licensing functions, and the exam tests them separately: individual pharmacists are licensed by the Board of Pharmacy, while pharmacy facilities are licensed through the Director of the Department of Health.
The District’s prescription drug monitoring program reaches beyond the controlled-substance schedules: alongside Schedule II–V dispensing, products containing gabapentin, butalbital or cyclobenzaprine are reportable as drugs of concern. A dispenser reports within 24 hours of dispensing — and files a zero report for any 24-hour period with no covered dispensing. The check duty binds dispensers as well as prescribers: before dispensing an opioid or benzodiazepine for an anticipated course of more than 7 days, and before a refill more than 90 days after the initial fill or the previous refill, the program must be checked; prescribers run the same check before starting a course of more than 7 days and every 90 days during therapy. A prescriber or dispenser may register at most two delegates.
District substitution law is permissive, with a purchaser’s edge: a pharmacist may substitute a generically equivalent drug or an interchangeable biological product, and must substitute when the purchaser asks. Any substitution — and any prescription written by generic name — must be filled with the in-stock product at the lowest cost to the purchaser. A prescriber’s do-not-substitute direction counts only in the prescriber’s own handwriting on a signed order; a checked or initialed preprinted box is expressly invalid. For an interchangeable biologic, the prescriber must be told the specific product dispensed and its manufacturer within 5 business days after dispensing, unless no interchangeable product is approved for the drug prescribed or the refill is unchanged.
The District schedules controlled substances its own way. The Mayor schedules by rule, and following a federal scheduling action is permitted, not automatic. In the D.C. Code itself, cannabis sits in Schedule III and buprenorphine in Schedule V — placements that differ from federal law, so on this exam the federal answer can be the wrong answer. Controlled-substance registration is annual, renewal is filed at least 60 days before expiration or the registration abates, and pharmacies register as dispensers — there is no pharmacy exemption. Three District dispensing rules draw questions every cycle: over-the-counter Schedule V sales are capped per purchaser per 48 hours, sold only by a pharmacist to a purchaser 18 or older and recorded in a bound logbook; Schedule III–V prescription information may be transferred between pharmacies only once; and an emergency oral Schedule II order is capped at a 7-day supply, with the prescriber’s covering written prescription due within 7 days.
District pharmacists may order and administer vaccines under the ACIP schedules when Board-certified — adults 18 and older with valid identification, and children and adolescents ages 3 through 17 with written informed parental consent. A Board-certified pharmacist working under the joint pharmacy and medicine protocol may prescribe and dispense up to a 12-month supply of self-administered hormonal contraceptives. Naloxone follows a bright line: a pharmacist dispenses or distributes it under a written protocol and standing order, but does not prescribe it. And two widely repeated claims are not District law: there is no District e-prescribing mandate, and there is no statutory cap on opioid day supply — the 7-day figure in District law is a prescription-monitoring check trigger, not a prescribing limit.
The people rules run on two-year cycles. Pharmacists complete 40 hours of continuing education every two years — at least 10 of them live and no more than 30 by home study — including 2 hours on medication and dispensing errors and 2 hours of LGBTQ cultural competency training. Internship comes in several shapes: a 1,000-hour college-administered program or 1,500 hours of independent practice, with 400 additional distribution-focused hours required since the class of 2014; and a pharmacist may supervise only one intern at a time without prior Board approval. Pharmacy technicians are registered, not licensed, and the District sets no numeric pharmacist-to-technician ratio — the standard is how many technicians and trainees a pharmacist can safely supervise. A District pharmacy answers to a pharmacist-in-charge, prescription records are kept five years, and the pharmacy rules state a $500 biennial facility license fee ($400 to register a non-resident pharmacy).
What changes on March 1, 2027?
From March 1, 2027, NABP replaces the MPJE Competency Statements with a new Content Outline: Pharmacy and Pharmacist Practice 30%, Medication Use Process 30%, Regulatory Authority and Legal Obligations 20%, and Pharmacy Operations 20%. Every question in this bank is dual-tagged to both blueprints, so the program’s practice exams re-weight to the new outline when the change takes effect — the questions you practice stay the right questions, at the new weights. Candidates testing before March 1, 2027 prepare against the current Competency Statements, which is how the bank is weighted today.
How should you use this program?
Work the bank in three passes. First, take a full 100-question practice exam under the 150-minute clock to find your baseline — the per-area results show exactly where the points are being lost. Second, drill the weakest competency area in focused sets, reading the explanation for every item, right or wrong: each explanation states why the keyed answer is right, so a wrong drill answer becomes a rule learned rather than a guess missed. Third, return to full practice exams drawn fresh from the bank — questions you have not seen come first, so a rising score reflects broader coverage rather than memorized items. In the final week, shift the drill mix toward District of Columbia law: it is the half of the exam that no national review book teaches, and it is where candidates who prepared generically lose the most ground.
What does the program cost?
The District of Columbia MPJE program is $49 for the full bank — all 1,500 questions, full-length practice exams, and per-area drills. Enrollment opens soon; join the notify list and we will email you when it opens.
Frequently asked questions
How many questions are on the District of Columbia MPJE?
The exam administers 120 questions in 2.5 hours: 100 scored questions and 20 unscored pretest questions mixed in so they cannot be told apart. Your result rests on the 100 scored questions.
What score do you need to pass the District of Columbia MPJE?
The MPJE is reported pass/fail against NABP’s passing standard. NABP does not publish a raw passing score, so no percentage — including the 70% benchmark this program uses in practice — is the passing standard. Older guides that quote a numeric scaled threshold describe how the exam used to be reported, not how it is reported now.
Can an MPJE score transfer to another state?
No. MPJE scores are not transferable between jurisdictions. A pass for District of Columbia supports District of Columbia licensure only; licensing in another MPJE state means that state’s MPJE as well. (Score transfer belongs to the separate Uniform MPJE used in other jurisdictions.)
How many times can you take the District of Columbia MPJE?
Up to 5 attempts per jurisdiction. NABP fees run about $270 per attempt, so preparation before the first sitting is the less expensive route.
Who confirms eligibility for the District of Columbia MPJE?
Eligibility is confirmed by NABP (the District of Columbia is one of the jurisdictions for which NABP confirms eligibility). You apply through NABP’s e-Profile, and eligibility must be confirmed before you can schedule at Pearson VUE.
Does the exam separate federal questions from District of Columbia questions?
No — NABP states that no distinction is made in the examination between federal and state jurisprudence questions, and each question is answered under the prevailing law of District of Columbia. Where the District of Columbia rule and the federal rule differ, the District of Columbia rule decides.
What does this program cover?
1,500 original practice questions: an 800-question federal core (controlled substances, FDA and dispensing law, compounding, privacy, licensure principles) intermixed with 700 questions on District of Columbia pharmacy law, weighted to NABP’s four competency areas at 22/33/24/21 percent.
Does every question really have an explanation?
Yes — all 1,500 questions in this bank carry an explanation of why the keyed answer is right, verified from the bank files when this page was built.
What happens to my preparation when the blueprint changes in March 2027?
Nothing is lost. Every question is dual-tagged to the current Competency Statements and to the March 1, 2027 Content Outline, and the program re-weights its practice exams to the new outline — 30/30/20/20 — when the change takes effect.
Is this program affiliated with NABP or District of Columbia Board of Pharmacy?
No. PassProfessor is an independent exam-preparation provider and is not affiliated with NABP, Pearson VUE, or District of Columbia Board of Pharmacy. The program provides practice questions for preparation; it is not a licensure requirement and confers no eligibility.
When can you enroll?
The program opens for enrollment soon at $49. Join the notify list on this page and we will email you when enrollment opens.
Disclaimer
PassProfessor is an independent exam-preparation provider, based in Salt Lake City, Utah and delivered entirely online. It is not affiliated with NABP, Pearson VUE, or District of Columbia Board of Pharmacy, and this program is preparation only — it is not pre-licensing education, confers no eligibility, and does not replace the official sources. Exam facts on this page are stated as of November 2026 from NABP and District of Columbia primary sources; confirm current requirements with NABP and District of Columbia Board of Pharmacy before you apply.
—